4D Molecular Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
4D Molecular Therapeutics, Inc.
CIK #0001650648
EDGAR Form CIK 2011 - 2025
10-K [0001650648]
10-Q [0001650648]
3 [0001650648]
4 [0001650648]
8-K [0001650648]
D [0001650648]
SC 13G [0001650648]
Form 13D/13G Filer Form 13D/13G Subject Filed
Goldman Sachs Group Inc 4D Molecular Therapeutics Inc [2024-11-06]
Vanguard Group Inc 4D Molecular Therapeutics Inc [2024-11-04]
RA Capital Management LP 4D Molecular Therapeutics Inc [2023-06-05]
Venrock Healthcare Capital Partners III LP 4D Molecular Therapeutics Inc [2023-05-15]
Janus Henderson Group PLC 4D Molecular Therapeutics Inc [2022-02-11]
BlackRock Inc 4D Molecular Therapeutics Inc [2022-02-04]
Deep Track Capital LP 4D Molecular Therapeutics Inc [2021-11-04]
Biotechnology Value Fund L P 4D Molecular Therapeutics Inc [2021-07-06]
Pfizer Inc 4D Molecular Therapeutics Inc [2021-02-16]
Schaffer David 4D Molecular Therapeutics Inc [2021-02-16]
View All
Form 3/4/5 Subject 2011 - 2025
4D Molecular Therapeutics, Inc.
Gray Susannah
Milligan John F
Miller-Rich Nancy
Theuer Charles
Tomasello Shawn
Chacko Jacob
Kamal Fariborz
Mehra Uneek
Kim Robert Young
View All
Terms | Privacy | Guide
tony@aum13f.com